title: T Cell Activation and Proinflammatory Cytokine Production in Clinically Cured Tuberculosis Are Time-Dependent and Accompanied by Upregulation of IL-10.
abstract: Th1 cytokines are essential for the control of M. tuberculosis infection. The role of IL-10 in tuberculosis is controversial and there is an increasing body of evidence suggesting that the relationship between Th1 cytokines and IL-10 is not as antagonistic as it was first believed, and that these cytokines may complement each other in infectious diseases.
  
  
  
  The present study evaluated the activating capacity of CD4+ and CD8+ T cell repertoire in response to antigen stimulation through the expression of CD69 using Flow Cytometry, as well as the functionality of PBMCs by determining the cytokine profile in patients with active tuberculosis and in clinically cured patients after in vitro stimulation using ELISA. Treated patients were subdivided according to time after clinical cure (<12 months or >12 months post-treatment).
  
  
  
  We observed that T cell activation was higher in TB-treated patients, especially CD8+ T cell activation in TB-Treated >1 year. Th1 cytokines were significantly higher in TB-Treated, and the levels of IFN-γ and TNF-α increased continuously after clinical cure. Moreover, IL-10 production was significantly higher in cured patients and it was also enhanced in cured patients over time after treatment. Th17, Th2 and Th22 cytokines showed no statistically significant differences between Healthy Donors, Active-TB and TB-Treated.
  
  
  
  This study describes a scenario in which potentiation of CD4+ and CD8+ T cell activation and increased Th1 cytokine production are associated with the clinical cure of tuberculosis in the absence of significant changes in Th2 cytokine production and is accompanied by increased production of IL-10. In contrast to other infections with intracellular microorganisms, this response occurs later after the end of treatment.
authors.affiliation: Laboratory of Immunology, Department of Biological Sciences, Triângulo Mineiro Federal University, Uberaba, Minas Gerais, Brazil.
authors.forename: Marcos Vinícius
authors.initials: MV
authors.lastname: da Silva
authors.forename: Amanda A
authors.initials: AA
authors.lastname: Figueiredo
authors.forename: Juliana R
authors.initials: JR
authors.lastname: Machado
authors.forename: Lúcio C
authors.initials: LC
authors.lastname: Castellano
authors.forename: Patricia B D
authors.initials: PB
authors.lastname: Alexandre
authors.forename: Rafael F
authors.initials: RF
authors.lastname: Oliveira
authors.forename: Gladstone E L
authors.initials: GE
authors.lastname: Faria
authors.forename: Sanívia A L
authors.initials: SA
authors.lastname: Pereira
authors.forename: Denise B R
authors.initials: DB
authors.lastname: Rodrigues
authors.forename: Virmondes
authors.initials: V
authors.lastname: Rodrigues
mesh_terms: D000328:Adult; D016207:Cytokines / Q000097:blood*; D005260:Female; D006801:Humans; D018836:Inflammation Mediators / Q000097:blood*; D016753:Interleukin-10 / Q000378:metabolism*; D008213:Lymphocyte Activation; D008297:Male; D013601:T-Lymphocytes / Q000276:immunology*; D013997:Time Factors; D014376:Tuberculosis / Q000097:blood / Q000276:immunology*; D015854:Up-Regulation
chemical_list: D016207:Cytokines; D018836:Inflammation Mediators; D016753:Interleukin-10